Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.accesswire.com/854020/jaguar-health-appoints-biopharmaceutical-industry-veteran-to-execute-companys-in-licensing-growth-strategy-in-the-areas-of-cancer-and-gi-supportive-care
https://www.accesswire.com/853212/jaguar-health-licenses-fda-approved-oral-mucositis-product-for-us-market-initiating-commercial-footprint-in-its-core-focus-area-of-cancer-supportive-care
https://www.accesswire.com/851238/jaguar-health-reports-approval-of-all-proposals-at-april-2024-special-meeting-of-stockholders
https://www.accesswire.com/850672/jaguar-health-granted-extension-until-august-13-2024-to-regain-compliance-with-nasdaqs-bid-price-requirement
https://www.accesswire.com/848894/jaguar-health-appoints-european-pharmaceutical-industry-leader-as-president-of-jaguar-international
https://www.accesswire.com/848441/jaguar-health-reports-2023-financial-results
https://www.accesswire.com/847144/jaguar-health-to-hold-investor-webcast-monday-april-1st-at-830-am-eastern-regarding-q4-2023-financials-corporate-updates
https://www.accesswire.com/844625/gen-to-commercialize-jaguar-healths-crofelemer-in-turkey-and-eight-neighboring-countries-and-invest-2-million-in-jaguar-stock-at-75-premium-to-market